Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuelle Viguier

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
The World Allergy Organization Journal|August 19, 2024
Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumabRémi Strizzolo, Julien Seneschal, Angèle Soria, et al.
Acta Dermato-Venereologica|May 28, 2015
No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case seriesCharlotte Hurabielle, Christophe Bedane, Martine Avenel-Audran, et al.
Experimental Dermatology|March 16, 2023
Human papilloma virus-16-specific CD8+ T-cell expansions characterize different clinical forms of lichen planus and not lichen sclerosus et atrophicusManuelle Viguier, Corine Pérals, Béatrice Poirier, et al.
Arthritis and Rheumatism|June 3, 2008
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasisManuelle Viguier, Pascal Richette, François Aubin, et al.
Melanoma Research|December 8, 2016
Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patientsReyhan Amode, Barouyr Baroudjian, Anita Kowal, et al.
Plos One|May 22, 2015
Online training on skin cancer diagnosis in rheumatologists: results from a nationwide randomized web-based surveyManuelle Viguier, Stéphanie Rist, François Aubin, et al.
Melanoma Research|September 24, 2015
BRAF inhibitor rechallenge in patients with advanced BRAF V600-mutant melanomaJennifer Roux, Cecile Pages, Diane Malouf, et al.
Melanoma Research|November 19, 2013
Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a single-centre trialFeriel Fennira, Cecile Pagès, Pierre Schneider, et al.
The Journal of Investigative Dermatology|September 17, 2020
Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell PopulationsFlorence Le Duff, Jean-David Bouaziz, Eric Fontas, et al.
European Journal of Dermatology : EJD|December 16, 2014
Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroidsFrançois Chasset, Cécile Pages, Lucie Biard, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
The World Allergy Organization Journal|August 19, 2024
Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumabRémi Strizzolo, Julien Seneschal, Angèle Soria, et al.
Acta Dermato-Venereologica|May 28, 2015
No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case seriesCharlotte Hurabielle, Christophe Bedane, Martine Avenel-Audran, et al.
Experimental Dermatology|March 16, 2023
Human papilloma virus-16-specific CD8+ T-cell expansions characterize different clinical forms of lichen planus and not lichen sclerosus et atrophicusManuelle Viguier, Corine Pérals, Béatrice Poirier, et al.
Arthritis and Rheumatism|June 3, 2008
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasisManuelle Viguier, Pascal Richette, François Aubin, et al.
Melanoma Research|December 8, 2016
Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patientsReyhan Amode, Barouyr Baroudjian, Anita Kowal, et al.
Plos One|May 22, 2015
Online training on skin cancer diagnosis in rheumatologists: results from a nationwide randomized web-based surveyManuelle Viguier, Stéphanie Rist, François Aubin, et al.
Melanoma Research|September 24, 2015
BRAF inhibitor rechallenge in patients with advanced BRAF V600-mutant melanomaJennifer Roux, Cecile Pages, Diane Malouf, et al.
Melanoma Research|November 19, 2013
Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a single-centre trialFeriel Fennira, Cecile Pagès, Pierre Schneider, et al.
The Journal of Investigative Dermatology|September 17, 2020
Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell PopulationsFlorence Le Duff, Jean-David Bouaziz, Eric Fontas, et al.
European Journal of Dermatology : EJD|December 16, 2014
Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroidsFrançois Chasset, Cécile Pages, Lucie Biard, et al.
Pageof 12